Posts

Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology

Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology

The technology may be more broadly used in the future for neuroscientific or physiological studies of brain activity during psychedelic use.
Psychedelic Business Spotlight — January 14

Psychedelic Business Spotlight — January 14

This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine trial delivers; and another patent is issued.
Ketamine Trial for Alcohol Use Disorder Delivers Very Promising ResultsShutterstock

Ketamine Trial for Alcohol Use Disorder Delivers Very Promising Results

Awakn Life Sciences' Head of Ketamine-Assisted Therapy, Professor Celia Morgan, says world’s first controlled trial to investigate efficacy of ketamine-assisted therapy for treatment of Alcohol Use Disorder "paves the way for a paradigm shift."
Is ‘The Trip’ Essential to The Psychedelic Experience?

Is ‘The Trip’ Essential to The Psychedelic Experience?

Biology and experience are tough to separate, but some researchers are exploring the possibility of non-hallucinogenic psychedelics as a mental health treatment. This begs the question: what do we lose, and what do we gain when we take the trip out of the psychedelic experience?

Interview with Matt Stang, CEO of Delic Corp

Co-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs and more.
Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Psychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest ketamine can also treat anxiety among other mental health issues.
Combining Psychedelics: Is It Safe?

Combining Psychedelics: Is It Safe?

Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and candy flipping (MDMA and LSD), to name two. Depending on how you go about it, the experience can be life-affirmingly euphoric or severely overwhelming. But is it ever worth the risk?
Psychedelic Business Spotlight: November 26

Psychedelic Business Spotlight: November 26

This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.
PharmaTher Believes Ketamine Could Treat This Rare Neurological ConditionShutterstock.com

PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition

,
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.